{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:18:01Z","timestamp":1790914681465,"version":"4.1.0"},"reference-count":45,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006254","name":"Ruhr University Bochum","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100006254","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that severely impairs quality of life. Treatment typically involves a patient-oriented combination of medical therapies, surgery, and lifestyle modifications. However, data on the impact of surgical treatments on quality of life remain limited. This prospective monocentric study aimed to evaluate the effect of wide surgical excision in patients with moderate to severe HS (Hurley stage II\/III) who were na\u00efve to systemic biologic treatments. Between March 2017 and November 2022, 82 patients (51% female; 80% Hurley II, 20% Hurley III) underwent major surgical excision. Assessments were performed before surgery and at three and six months postoperatively. The primary endpoint was the change in Dermatologic Life Quality Index (DLQI); secondary endpoints included changes in pain (NRS-11) and disease severity scores. DLQI improved from 11.7 at baseline to 8.3 at three months and 4.7 at six months (p &lt; 0.001). Pain scores and the modified Hidradenitis Suppurativa Score (mHSS) also significantly decreased (p &lt; 0.001). In conclusion, major surgery significantly improved quality of life and pain in HS patients, confirming its essential role in a multimodal treatment approach. Patient-reported outcome measures are crucial for assessing treatment efficacy in HS.<\/jats:p>","DOI":"10.3390\/life15050769","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T09:26:48Z","timestamp":1747128408000},"page":"769","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Impact of Surgery on Quality of Life in Hidradenitis Suppurativa: Results from a Prospective Single-Center Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3653-1560","authenticated-orcid":false,"given":"Lennart","family":"Ocker","sequence":"first","affiliation":[{"name":"International Centre for Hidradenitis Suppurativa\/Acne Inversa (ICH), Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, 44791 Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6853-0743","authenticated-orcid":false,"given":"Nessr","family":"Abu Rached","sequence":"additional","affiliation":[{"name":"International Centre for Hidradenitis Suppurativa\/Acne Inversa (ICH), Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, 44791 Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Koller","sequence":"additional","affiliation":[{"name":"International Centre for Hidradenitis Suppurativa\/Acne Inversa (ICH), Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, 44791 Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Frost","sequence":"additional","affiliation":[{"name":"International Centre for Hidradenitis Suppurativa\/Acne Inversa (ICH), Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, 44791 Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riina","family":"K\u00e4pynen","sequence":"additional","affiliation":[{"name":"International Centre for Hidradenitis Suppurativa\/Acne Inversa (ICH), Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, 44791 Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk G.","family":"Bechara","sequence":"additional","affiliation":[{"name":"International Centre for Hidradenitis Suppurativa\/Acne Inversa (ICH), Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, 44791 Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-020-0149-1","article-title":"Hidradenitis suppurativa","volume":"6","author":"Sabat","year":"2020","journal-title":"Nat. Rev. Dis. Primer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jamadermatol.2017.0201","article-title":"Sex- and Age-Adjusted Population Analysis of Prevalence Estimates for Hidradenitis Suppurativa in the United States","volume":"153","author":"Garg","year":"2017","journal-title":"JAMA Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/bjd.16998","article-title":"Prevalence of Patients with Self-Reported Hidradenitis Suppurativa in a Cohort of Danish Blood Donors: A Cross-Sectional Study","volume":"180","author":"Pedersen","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/bjd.16101","article-title":"Population-Based Clinical Practice Research Datalink Study Using Algorithm Modelling to Identify the True Burden of Hidradenitis Suppurativa","volume":"178","author":"Ingram","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaad.2020.09.039","article-title":"Pain Management in Hidradenitis Suppurativa and a Proposed Treatment Algorithm","volume":"85","author":"Savage","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/AJP.0b013e3181ceb80c","article-title":"Painful Hidradenitis Suppurativa","volume":"26","author":"Smith","year":"2010","journal-title":"Clin. J. Pain"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.2340\/00015555-2561","article-title":"Impairment of Sexual Life in 3,485 Dermatological Outpatients from a Multicentre Study in 13 European Countries","volume":"97","author":"Sampogna","year":"2017","journal-title":"Acta Derm. Venereol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Ocker, L., Abu Rached, N., Seifert, C., Scheel, C., and Bechara, F.G. (2022). Current Medical and Surgical Treatment of Hidradenitis Suppurativa-A Comprehensive Review. J. Clin. Med., 11.","DOI":"10.3390\/jcm11237240"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa","volume":"375","author":"Kimball","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(23)00022-3","article-title":"Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa (SUNSHINE and SUNRISE): Week 16 and Week 52 Results of Two Identical, Multicentre, Randomised, Placebo-Controlled, Double-Blind Phase 3 Trials","volume":"401","author":"Kimball","year":"2023","journal-title":"Lancet Lond. Engl."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/S0140-6736(24)00101-6","article-title":"Efficacy and Safety of Bimekizumab in Patients with Moderate-to-Severe Hidradenitis Suppurativa (BE HEARD I and BE HEARD II): Two 48-Week, Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase 3 Trials","volume":"403","author":"Kimball","year":"2024","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/09546634.2018.1467537","article-title":"A Note on Improvement in Dermatology Life Quality Index (DLQI) among Patients with Hidradenitis Suppurativa Treated with Adalimumab","volume":"29","author":"Thomsen","year":"2018","journal-title":"J. Dermatol. Treat."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/jdv.16023","article-title":"Weekly Adalimumab Treatment Decreased Disease Flare in Hidradenitis Suppurativa over 36 Weeks: Integrated Results from the Phase 3 PIONEER Trials","volume":"34","author":"Longcore","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s00105-021-04864-8","article-title":"Hidradenitis suppurativa\/acne inversa-surgical options, reconstruction and combinations with drug therapies-an update","volume":"72","author":"Cramer","year":"2021","journal-title":"Hautarzt Z. Dermatol. Venerol. Verwandte Geb."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000431175","article-title":"Hidradenitis Suppurativa\/Acne Inversa: Criteria for Diagnosis, Severity Assessment, Classification and Disease Evaluation","volume":"231","author":"Zouboulis","year":"2015","journal-title":"Dermatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)\u2014a Simple Practical Measure for Routine Clinical Use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_17","unstructured":"Harry, J. (1996). Hurley Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial benign pemphigus: Surgical approach. Roenigk & Roenigk\u2019s Dermatologic Surgery: Principles and Practice, Marcel Dekker Inc.. [2nd ed.]."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective Scoring of Hidradenitis Suppurativa Reflecting the Role of Tobacco Smoking and Obesity","volume":"161","author":"Sartorius","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1365-2702.2005.01121.x","article-title":"Pain: A Review of Three Commonly Used Pain Rating Scales","volume":"14","author":"Williamson","year":"2005","journal-title":"J. Clin. Nurs."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Chernyshov, P.V., Finlay, A.Y., Tomas-Aragones, L., Poot, F., Sampogna, F., Marron, S.E., Zemskov, S.V., Abeni, D., Tzellos, T., and Szepietowski, J.C. (2021). Quality of Life in Hidradenitis Suppurativa: An Update. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18116131"},{"key":"ref_21","first-page":"137","article-title":"Patient-Reported Outcomes in Hidradenitis Suppurativa","volume":"154","author":"Vellaichamy","year":"2019","journal-title":"G. Ital. Dermatol. E Venereol. Organo Uff. Soc. Ital. Dermatol. E Sifilogr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.0022-202X.2005.23621.x","article-title":"Translating the Science of Quality of Life into Practice: What Do Dermatology Life Quality Index Scores Mean?","volume":"125","author":"Hongbo","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/bjd.18692","article-title":"The Hidradenitis Suppurativa Quality of Life (HiSQOL) Score: Development and Validation of a Measure for Clinical Trials","volume":"183","author":"Kirby","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_24","first-page":"554","article-title":"Development and Preliminary Validation of the HSQoL-24 Tool to Assess Quality of Life in Patients with Hidradenitis Suppurativa","volume":"110","author":"Puig","year":"2019","journal-title":"Actas Dermosifiliogr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaad.2017.08.030","article-title":"Hidradenitis Suppurativa Burden of Disease Tool: Pilot Testing of a Disease-Specific Quality of Life Questionnaire","volume":"78","author":"Pinard","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/1203475416677721","article-title":"Development of a Quality-of-Life Measure for Hidradenitis Suppurativa","volume":"21","author":"Sisic","year":"2017","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2018.05.040","article-title":"Long-Term Adalimumab Efficacy in Patients with Moderate-to-Severe Hidradenitis Suppurativa\/Acne Inversa: 3-Year Results of a Phase 3 Open-Label Extension Study","volume":"80","author":"Zouboulis","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Shukla, R., Karagaiah, P., Patil, A., Farnbach, K., Ortega-Loayza, A.G., Tzellos, T., Szepietowski, J.C., Giulini, M., Schepler, H., and Grabbe, S. (2022). Surgical Treatment in Hidradenitis Suppurativa. J. Clin. Med., 11.","DOI":"10.3390\/jcm11092311"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1055\/a-2225-7983","article-title":"S2k-Leitlinie zur Therapie der Hidradenitis suppurativa\/Acne inversa (ICD-10-Code: L73.2)","volume":"50","author":"Zouboulis","year":"2024","journal-title":"Aktuelle Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/jdv.20472","article-title":"European S2k Guidelines for Hidradenitis Suppurativa\/Acne Inversa Part 2: Treatment","volume":"39","author":"Zouboulis","year":"2025","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00403-024-03000-5","article-title":"A Review of Surgical and Reconstructive Techniques for Hidradenitis Suppurativa","volume":"316","author":"Wong","year":"2024","journal-title":"Arch. Dermatol. Res."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Schneider-Burrus, S., Tsaousi, A., Barbus, S., Huss-Marp, J., Witte, K., Wolk, K., Fritz, B., and Sabat, R. (2021). Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients. Front. Med., 8.","DOI":"10.3389\/fmed.2021.676241"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/jdv.15353","article-title":"Evaluation of Medical and Surgical Treatments for Hidradenitis Suppurativa Using Real-Life Data from the Scandinavian Registry (HISREG)","volume":"33","author":"Grimstad","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"key":"ref_34","first-page":"125","article-title":"Patient Satisfaction and Quality of Life Following Surgery for Hidradenitis Suppurativa","volume":"43","author":"Kohorst","year":"2017","journal-title":"Dermatol. Surg. Off. Publ. Am. Soc. Dermatol. Surg. Al"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/jdv.14892","article-title":"Surgical Treatment of Hidradenitis Suppurativa: An Analysis of Postoperative Outcome, Cosmetic Results and Quality of Life in 255 Patients","volume":"32","author":"Kofler","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/jdv.15706","article-title":"Surgical Outcomes and the Impact of Major Surgery on Quality of Life, Activity Impairment and Sexual Health in Hidradenitis Suppurativa Patients: A Prospective Single Centre Study","volume":"33","author":"Prens","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaad.2017.01.055","article-title":"The Role of Wide Local Excision for the Treatment of Severe Hidradenitis Suppurativa (Hurley Grade III): Retrospective Analysis of 74 Patients","volume":"77","author":"Posch","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_38","first-page":"1556","article-title":"Improvement in Quality of Life and Pain in Patients With Hidradenitis Suppurativa After Wide Local Excision: A Prospective Study","volume":"47","author":"Dick","year":"2021","journal-title":"Dermatol. Surg. Off. Publ. Am. Soc. Dermatol. Surg. Al"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jamasurg.2021.3655","article-title":"Efficacy and Safety of Adalimumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa: The SHARPS Randomized Clinical Trial","volume":"156","author":"Bechara","year":"2021","journal-title":"JAMA Surg."},{"key":"ref_40","first-page":"885","article-title":"Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert Panel","volume":"240","author":"Offidani","year":"2024","journal-title":"Dermatology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jaad.2023.04.034","article-title":"Adalimumab in Conjunction with Surgery Compared with Adalimumab Monotherapy for Hidradenitis Suppurativa: A Randomized Controlled Trial in a real-world setting","volume":"89","author":"Aarts","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/1346-8138.17375","article-title":"Adopting Adalimumab Combined Surgery in the Management of Moderate to Severe Hidradenitis Suppurativa: Experience from a Single Medical Center in Southern Taiwan","volume":"51","author":"Lai","year":"2024","journal-title":"J. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Ocker, L., Abu Rached, N., and Bechara, F.G. (2024). Surgical Management of Hidradenitis Suppurativa, IntechOpen. Dermatology\u2014The Latest Research on the Most Common Diseases.","DOI":"10.5772\/intechopen.1005024"},{"key":"ref_44","first-page":"235","article-title":"A Comparison of Skin Grafting and Healing by Granulation, Following Axillary Excision for Hidradenitis Suppurativa","volume":"65","author":"Morgan","year":"1983","journal-title":"Ann. R. Coll. Surg. Engl."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e030579","DOI":"10.1136\/bmjopen-2019-030579","article-title":"Disease Burden and Cost of Hidradenitis Suppurativa: A Retrospective Examination of US Administrative Claims Data","volume":"9","author":"Marvel","year":"2019","journal-title":"BMJ Open"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/5\/769\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:31:08Z","timestamp":1760031068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/5\/769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["life15050769"],"URL":"https:\/\/doi.org\/10.3390\/life15050769","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]}}}